Onclive articles Copyright (c) 2014 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Sun, 25 Jan 2015 16:14:51 UTC 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[Brahmer Expects Rapid Approval for First PD-1 Inhibitor in Lung Cancer]]>http://www.onclive.com/web-exclusives/Brahmer-Expects-Rapid-Approval-for-First-PD-1-Inhibitor-in-Lung-CancerOnclive articlesusSun, 25 Jan 2015 13:00:00 UTCOnclive<![CDATA[ Who Will Join the 2015 Class of the Giants of Cancer Care?]]>http://www.onclive.com/web-exclusives/-Who-Will-Join-the-2015-Class-of-the-Giants-of-Cancer-CareOnclive articlesusSat, 24 Jan 2015 14:00:00 UTCOnclive<![CDATA[Enzalutamide Improves PFS Over Bicalutamide in mCRPC ]]>http://www.onclive.com/web-exclusives/Enzalutamide-Improves-PFS-Over-Bicalutamide-in-mCRPC-Onclive articlesusFri, 23 Jan 2015 22:50:00 UTCOnclive<![CDATA[17 Cancer Drugs on Breakthrough Therapy List]]>http://www.onclive.com/web-exclusives/17-Cancer-Drugs-on-Breakthrough-Therapy-ListOnclive articlesusFri, 23 Jan 2015 18:56:00 UTCOnclive<![CDATA[Precision Medicine Goes Mainstream]]>http://www.onclive.com/web-exclusives/Precision-Medicine-Whats-Next-Onclive articlesusThu, 22 Jan 2015 22:02:00 UTCOnclive<![CDATA[Liposome Injection CPX-351 Receives Fast Track Designation for Relapsed AML ]]>http://www.onclive.com/web-exclusives/Liposome-Injection-CPX-351-Receives-Fast-Track-Designation-for-Relapsed-AML-Onclive articlesusThu, 22 Jan 2015 18:09:00 UTCOnclive<![CDATA[CancerLinQ To Be Rolled Out to 15 Community Practices, Large Cancer Centers]]>http://www.onclive.com/web-exclusives/CancerLinQ-To-Be-Rolled-Out-to-15-Community-Practices-Large-Cancer-CentersOnclive articlesusWed, 21 Jan 2015 07:22:35 UTCOnclive<![CDATA[Multitargeted Drug Slows CRC as Third-Line Therapy]]>http://www.onclive.com/conference-coverage/gi-2015/Multitargeted-Drug-Slows-CRC-as-Third-Line-TherapyOnclive articlesusWed, 21 Jan 2015 05:21:39 UTCOnclive<![CDATA[Trastuzumab Regimen Lowers Recurrence Risk in Early-Stage, HER2-Positive Breast Cancer]]>http://www.onclive.com/web-exclusives/Trastuzumab-May-Reduce-Recurrence-of-HER2-Positive-Breast-CancerOnclive articlesusTue, 20 Jan 2015 23:44:14 UTCOnclive<![CDATA[Complexities of Translating PD-1/PD-L1 Agents to Clinical Practice Emerge]]>http://www.onclive.com/publications/Oncology-live/2015/January-2015/Complexities-of-Translating-PD-1PD-L1-Agents-to-Clinical-Practice-EmergeOnclive articlesusTue, 20 Jan 2015 21:25:01 UTCOnclive